{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:45:49Z","timestamp":1783975549721,"version":"3.55.0"},"reference-count":110,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00340","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T05:53:44Z","timestamp":1519624424000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Early Growth Response Gene 2-Expressing CD4+LAG3+ Regulatory T Cells: The Therapeutic Potential for Treating Autoimmune Diseases"],"prefix":"10.3389","volume":"9","author":[{"given":"Tomohisa","family":"Okamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Fujio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1568-9972(03)00006-5","article-title":"The epidemiology of autoimmune diseases","volume":"2","author":"Cooper","year":"2003","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1038\/mt.2012.71","article-title":"Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4+ T cells","volume":"20","author":"Andolfi","year":"2012","journal-title":"Mol Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fimmu.2017.00031","article-title":"CD28- and CD28lowCD8+ regulatory T cells: of mice and men","volume":"8","author":"Vuddamalay","year":"2017","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1172\/JCI85113","article-title":"Human regulatory B cells in health and disease: therapeutic potential","volume":"127","author":"Mauri","year":"2017","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2015.07.011","article-title":"Regulatory dendritic cells in autoimmunity: a comprehensive review","volume":"63","author":"Liu","year":"2015","journal-title":"J Autoimmun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2047-1440-1-17","article-title":"Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs","volume":"1","author":"Riquelme","year":"2012","journal-title":"Transplant Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fimmu.2012.00184","article-title":"Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation","volume":"3","author":"Sagoo","year":"2012","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1182\/blood-2008-05-156612","article-title":"CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses","volume":"113","author":"Verma","year":"2009","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1084\/jem.20081359","article-title":"Antigen-specific peripheral shaping of the natural regulatory T cell population","volume":"205","author":"Lathrop","year":"2008","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.immuni.2011.03.029","article-title":"A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity","volume":"35","author":"Haribhai","year":"2011","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature08750","article-title":"Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate","volume":"463","author":"Zheng","year":"2010","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"13974","DOI":"10.1073\/pnas.0906872106","article-title":"CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2","volume":"106","author":"Okamura","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1126\/science.1142331","article-title":"Emerging challenges in regulatory T cell function and biology","volume":"317","author":"Sakaguchi","year":"2007","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat Genet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0022-3476(82)80573-8","article-title":"An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy","volume":"100","author":"Powell","year":"1982","journal-title":"J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/ni.2554","article-title":"Regulatory T cells: recommendations to simplify the nomenclature","volume":"14","author":"Abbas","year":"2013","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"tTregs, pTregs, and iTregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fimmu.2012.00030","article-title":"The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells","volume":"3","author":"Gregori","year":"2012","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3389\/fimmu.2015.00593","article-title":"Clinical outlook for type-1 and FOXP3(+) T regulatory cell-based therapy","volume":"6","author":"Gregori","year":"2015","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10-secreting type 1 regulatory T cells in rodents and humans","volume":"212","author":"Roncarolo","year":"2006","journal-title":"Immunol Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1084\/jem.170.6.2081","article-title":"Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones","volume":"170","author":"Fiorentino","year":"1989","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.immuni.2009.05.012","article-title":"Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose","volume":"31","author":"Saraiva","year":"2009","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature10957","article-title":"Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta","volume":"484","author":"Zielinski","year":"2012","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1600-065X.2008.00635.x","article-title":"Strategies for use of IL-10 or its antagonists in human disease","volume":"223","author":"O\u2019Garra","year":"2008","journal-title":"Immunol Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ni1504","article-title":"Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10","volume":"8","author":"Maynard","year":"2007","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1084\/jem.179.2.493","article-title":"High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells","volume":"179","author":"Bacchetta","year":"1994","journal-title":"J Exp Med"},{"key":"B32","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.4049\/jimmunol.149.7.2378","article-title":"IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells","volume":"149","author":"Yssel","year":"1992","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.7520605","article-title":"Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis","volume":"265","author":"Chen","year":"1994","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.smim.2006.01.007","article-title":"Tr1 cells: from discovery to their clinical application","volume":"18","author":"Battaglia","year":"2006","journal-title":"Semin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nm.3179","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/ncomms5741","article-title":"Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy","volume":"5","author":"Burton","year":"2014","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of LAG-3 in regulatory T cells","volume":"21","author":"Huang","year":"2004","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1002\/1521-4141(200208)32:8<2255:AID-IMMU2255>3.0.CO;2-A","article-title":"Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3)","volume":"32","author":"Workman","year":"2002","journal-title":"Eur J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"i96","DOI":"10.1136\/annrheumdis-2011-200588","article-title":"Roles of LAG3 and EGR2 in regulatory T cells","volume":"71","author":"Okamura","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"Kuhn","year":"1993","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1749-6632.1998.tb08314.x","article-title":"Role of IL-10 in inflammation. Studies using cytokine knockout mice","volume":"856","author":"Leon","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S1359-6101(02)00025-4","article-title":"The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS)","volume":"13","author":"Beebe","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1172\/JCI21795","article-title":"Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice","volume":"114","author":"Hata","year":"2004","journal-title":"J Clin Invest"},{"key":"B45","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.161.7.3299","article-title":"IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice","volume":"161","author":"Bettelli","year":"1998","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/371796a0","article-title":"Krox-20 controls myelination in the peripheral nervous system","volume":"371","author":"Topilko","year":"1994","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","first-page":"7331","DOI":"10.4049\/jimmunol.173.12.7331","article-title":"Early growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells","volume":"173","author":"Harris","year":"2004","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/ni1193","article-title":"Egr-2 and Egr-3 are negative regulators of T cell activation","volume":"6","author":"Safford","year":"2005","journal-title":"Nat Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1084\/jem.20080187","article-title":"Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease","volume":"205","author":"Zhu","year":"2008","journal-title":"J Exp Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/eji.201242942","article-title":"Egr-2 transcription factor is required for Blimp-1-mediated IL-10 production in IL-27-stimulated CD4+ T cells","volume":"43","author":"Iwasaki","year":"2013","journal-title":"Eur J Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1084\/jem.20131548","article-title":"Role of Blimp-1 in programing Th effector cells into IL-10 producers","volume":"211","author":"Neumann","year":"2014","journal-title":"J Exp Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/ni.1996","article-title":"CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs","volume":"12","author":"Sun","year":"2011","journal-title":"Nat Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1084\/jem.20160553","article-title":"Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation","volume":"214","author":"Miao","year":"2017","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/eji.200635883","article-title":"Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance","volume":"36","author":"Anderson","year":"2006","journal-title":"Eur J Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"16484","DOI":"10.1073\/pnas.1417215111","article-title":"EGR2 is critical for peripheral naive T-cell differentiation and the T-cell response to influenza","volume":"111","author":"Du","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e12904","DOI":"10.1371\/journal.pone.0012904","article-title":"EGR-2 is not required for in vivo CD4 T cell mediated immune responses","volume":"5","author":"Ramon","year":"2010","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4049\/jimmunol.1200868","article-title":"Early growth response gene-2 controls IL-17 expression and Th17 differentiation by negatively regulating Batf","volume":"190","author":"Miao","year":"2013","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"20455","DOI":"10.1074\/jbc.M114.634816","article-title":"Early growth response genes 2 and 3 regulate the expression of Bcl6 and differentiation of T follicular helper cells","volume":"290","author":"Ogbe","year":"2015","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.immuni.2012.08.001","article-title":"The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells","volume":"37","author":"Li","year":"2012","journal-title":"Immunity"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.4049\/jimmunol.180.5.2752","article-title":"Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells","volume":"180","author":"Batten","year":"2008","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"key":"B62","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/ni.1912","article-title":"The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27","volume":"11","author":"Apetoh","year":"2010","journal-title":"Nat Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/ni.3683","article-title":"Critical role of IRF1 and BATF in forming chromatin landscape during type 1 regulatory cell differentiation","volume":"18","author":"Karwacz","year":"2017","journal-title":"Nat Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1474-4422(02)00042-X","article-title":"Hereditary motor and sensory neuropathies: a biological perspective","volume":"1","author":"Shy","year":"2002","journal-title":"Lancet Neurol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","year":"2007","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/ng2032","article-title":"Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis","volume":"39","author":"Rioux","year":"2007","journal-title":"Nat Genet"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/hmg\/ddq092","article-title":"Regulatory polymorphisms in EGR2 are associated with susceptibility to systemic lupus erythematosus","volume":"19","author":"Myouzen","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"B69","first-page":"S82","article-title":"New drugs in systemic lupus erythematosus: when to start and when to stop","volume":"31","author":"Mosca","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.berh.2016.02.007","article-title":"New therapeutic avenues in SLE","volume":"29","author":"Bakshi","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1038\/ncomms7329","article-title":"TGF-beta3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses","volume":"6","author":"Okamura","year":"2015","journal-title":"Nat Commun"},{"key":"B72","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/ni.2293","article-title":"TRIM28 prevents autoinflammatory T cell development in vivo","volume":"13","author":"Chikuma","year":"2012","journal-title":"Nat Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e0169646","DOI":"10.1371\/journal.pone.0169646","article-title":"TGF-beta3 inhibits antibody production by human B cells","volume":"12","author":"Tsuchida","year":"2017","journal-title":"PLoS One"},{"key":"B75","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.4049\/jimmunol.1101990","article-title":"Programmed cell death 1 suppresses B-1b cell expansion and long-lived IgG production in response to T cell-independent type 2 antigens","volume":"187","author":"Haas","year":"2011","journal-title":"J Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.it.2006.02.001","article-title":"The PD-1-PD-L pathway in immunological tolerance","volume":"27","author":"Okazaki","year":"2006","journal-title":"Trends Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.immuni.2011.01.020","article-title":"Th17 cells express interleukin-10 receptor and are controlled by Foxp3 and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner","volume":"34","author":"Huber","year":"2011","journal-title":"Immunity"},{"key":"B79","doi-asserted-by":"publisher","first-page":"E8131","DOI":"10.1073\/pnas.1611286114","article-title":"Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-beta3 production","volume":"113","author":"Morita","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B80","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1242\/jcs.00229","article-title":"Making sense of latent TGFbeta activation","volume":"116","author":"Annes","year":"2003","journal-title":"J Cell Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrm2262","article-title":"Extracellular control of TGFbeta signalling in vascular development and disease","volume":"8","author":"ten Dijke","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/10408360490460933","article-title":"Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation","volume":"41","author":"Hyytiainen","year":"2004","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/eji.200838346","article-title":"TGF-beta-induced Foxp3+ regulatory T cells rescue scurfy mice","volume":"38","author":"Huter","year":"2008","journal-title":"Eur J Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.4049\/jimmunol.177.3.1451","article-title":"Suppression of disease in New Zealand Black\/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells","volume":"177","author":"Scalapino","year":"2006","journal-title":"J Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0896-8411(03)00114-8","article-title":"CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells","volume":"21","author":"Mukherjee","year":"2003","journal-title":"J Autoimmun"},{"key":"B86","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.4049\/jimmunol.169.9.4712","article-title":"Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis","volume":"169","author":"Kohm","year":"2002","journal-title":"J Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.4049\/jimmunol.170.8.3939","article-title":"Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells","volume":"170","author":"Mottet","year":"2003","journal-title":"J Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1002\/art.21195","article-title":"Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells","volume":"52","author":"Morgan","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B89","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jmcb\/mjr047","article-title":"CD4(+)Foxp3(+) regulatory T cell therapy in transplantation","volume":"4","author":"Tang","year":"2012","journal-title":"J Mol Cell Biol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.34477","article-title":"Brief report: inhibition of interleukin-6 function corrects Th17\/Treg cell imbalance in patients with rheumatoid arthritis","volume":"64","author":"Samson","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B91","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13075-017-1309-x","article-title":"Interleukin-10-producing LAG3+ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis","volume":"19","author":"Nakachi","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B92","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.4049\/jimmunol.178.11.6725","article-title":"Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta","volume":"178","author":"Xu","year":"2007","journal-title":"J Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fimmu.2013.00233","article-title":"TNFR2 expression on CD25(hi)FOXP3(+) T cells induced upon TCR stimulation of CD4 T cells identifies maximal cytokine-producing effectors","volume":"4","author":"Govindaraj","year":"2013","journal-title":"Front Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/eji.200737590","article-title":"Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells","volume":"38","author":"Aarts-Riemens","year":"2008","journal-title":"Eur J Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/sj.mt.6300341","article-title":"Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3","volume":"16","author":"Allan","year":"2008","journal-title":"Mol Ther"},{"key":"B96","doi-asserted-by":"publisher","first-page":"215ra174","DOI":"10.1126\/scitranslmed.3007320","article-title":"CD4(+) T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer","volume":"5","author":"Passerini","year":"2013","journal-title":"Sci Transl Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/intimm\/dxh165","article-title":"Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells","volume":"16","author":"Yagi","year":"2004","journal-title":"Int Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1002\/eji.200526077","article-title":"Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation","volume":"35","author":"Albert","year":"2005","journal-title":"Eur J Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/sj.gt.3302567","article-title":"In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity","volume":"12","author":"Loser","year":"2005","journal-title":"Gene Ther"},{"key":"B100","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jaut.2007.02.015","article-title":"Converting antigen-specific diabetogenic CD4 and CD8 T cells to TGF-beta producing non-pathogenic regulatory cells following FoxP3 transduction","volume":"28","author":"Peng","year":"2007","journal-title":"J Autoimmun"},{"key":"B101","doi-asserted-by":"publisher","first-page":"8140","DOI":"10.4049\/jimmunol.177.11.8140","article-title":"Gene therapy of arthritis with TCR isolated from the inflamed paw","volume":"177","author":"Fujio","year":"2006","journal-title":"J Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jaci.2010.10.023","article-title":"Bet v 1-specific T-cell receptor\/forkhead box protein 3 transgenic T cells suppress Bet v 1-specific T-cell effector function in an activation-dependent manner","volume":"127","author":"Schmetterer","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.4049\/jimmunol.165.10.5980","article-title":"Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen","volume":"165","author":"Setoguchi","year":"2000","journal-title":"J Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nm.2128","article-title":"Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy","volume":"16","author":"Bendle","year":"2010","journal-title":"Nat Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1053\/j.gastro.2009.01.049","article-title":"Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor","volume":"136","author":"Elinav","year":"2009","journal-title":"Gastroenterology"},{"key":"B106","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"B107","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.biocel.2007.08.016","article-title":"Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3","volume":"40","author":"Ask","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1073\/pnas.92.7.2572","article-title":"Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions","volume":"92","author":"Sanderson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B109","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"304s318","DOI":"10.1126\/scitranslmed.aaa7721","article-title":"Hurdles in therapy with regulatory T cells","volume":"7","author":"Trzonkowski","year":"2015","journal-title":"Sci Transl Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00340\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T08:35:37Z","timestamp":1693557337000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00340\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":110,"alternative-id":["10.3389\/fimmu.2018.00340"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00340","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"article-number":"340"}}